<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Deloney M</submitter><funding>National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>NCATS NIH HHS</funding><funding>National Center for Advancing Translational Sciences of the</funding><funding>NIAMS NIH HHS</funding><funding>National Institutes of Health, United States of America</funding><pagination>47-58</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9930616</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>323</volume><pubmed_abstract>Inflammation following joint trauma contributes to cartilage degradation and progression of post traumatic osteoarthritis (PTOA). Therefore, drug delivery vehicles that deliver effective anti-inflammatory treatments have the potential to prevent PTOA. We have developed solid and hollow, thermoresponsive nanoparticles for the controlled release of our anti-inflammatory MK2-inhibiting (MK2i) peptide for intra-articular injection to halt inflammation that contributes to the advancement of PTOA. This system exploits the thermosensitive characteristic of N-isopropyl acrylamide (NIPAm) to transition phases when passing through its lower critical solution temperature (LCST). The nanoparticles (NPs) swell below the LCST and constrict above it. Non-crosslinked poly(NIPAm) (pNIPAm), held above its L</pubmed_abstract><journal>Journal of controlled release : official journal of the Controlled Release Society</journal><pubmed_title>Thermoresponsive, hollow, degradable core-shell nanoparticles for intra-articular delivery of anti-inflammatory peptide.</pubmed_title><pmcid>PMC9930616</pmcid><funding_grant_id>R01AR065398</funding_grant_id><funding_grant_id>UL1 TR001860</funding_grant_id><funding_grant_id>TL1 TR001861</funding_grant_id><funding_grant_id>R01 AR065398</funding_grant_id><pubmed_authors>Smart K</pubmed_authors><pubmed_authors>Deloney M</pubmed_authors><pubmed_authors>Christiansen BA</pubmed_authors><pubmed_authors>Panitch A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Thermoresponsive, hollow, degradable core-shell nanoparticles for intra-articular delivery of anti-inflammatory peptide.</name><description>Inflammation following joint trauma contributes to cartilage degradation and progression of post traumatic osteoarthritis (PTOA). Therefore, drug delivery vehicles that deliver effective anti-inflammatory treatments have the potential to prevent PTOA. We have developed solid and hollow, thermoresponsive nanoparticles for the controlled release of our anti-inflammatory MK2-inhibiting (MK2i) peptide for intra-articular injection to halt inflammation that contributes to the advancement of PTOA. This system exploits the thermosensitive characteristic of N-isopropyl acrylamide (NIPAm) to transition phases when passing through its lower critical solution temperature (LCST). The nanoparticles (NPs) swell below the LCST and constrict above it. Non-crosslinked poly(NIPAm) (pNIPAm), held above its L</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2026-03-17T15:44:56.263Z</modification><creation>2025-04-04T11:16:53.61Z</creation></dates><accession>S-EPMC9930616</accession><cross_references><pubmed>32278830</pubmed><doi>10.1016/j.jconrel.2020.04.007</doi></cross_references></HashMap>